All updated as on -
By 2031, the worldwide glutamine (GLN) market is expected to reach USD 200.81 million, up from USD 149.57 million in 2023, a compound annual growth rate (CAGR) of 5.3%.
The human body produces glutamine and other amino acids naturally. It is a crucial component of proteins and involved in many bodily functions. The correct functioning of muscles depends on glutamine, which is abundant in muscles. It helps with a lot of different biological functions, including the immune system and keeping the digestive tract healthy.
Additionally, the immune system cannot operate correctly without glutamine. It helps immune cells like macrophages and lymphocytes carry out their defense mechanisms by providing them with fuel. An important aspect of the immune defense system in humans is the gastrointestinal tract, which glutamine aids in preserving. And that's not all: glutamine aids in recuperation, wound healing, intestine health, and energy production. In addition, glutamine has many potential uses in the beauty and personal care industries.
The amino acid glutamine can be found in two distinct forms: L-glutamine and D-glutamine. The human body contains the D enantiomer of glutamine, which is called D-glutamine. It is involved in metabolic activities. It transports nitrogen across the body and provides energy to certain cells. However, L-glutamine calms intestinal tissues and increases immune cell activity, therefore reducing inflammation and infection in the gut. Additionally, it boosts immunity, helps with irritable bowel syndrome, and promotes digestive health.
Over the projected period, the global Glutamine (Gln) market is anticipated to maintain a consistent revenue CAGR, building on its robust performance in 2020. The existence of well-established enterprises worldwide, improvements in healthcare infrastructure, government programs aimed at raising public knowledge about the importance of health and wellness, and rising awareness about the need of maintaining immunological and gut health are all key drivers driving the market revenue growth.
Glutamine is a necessary amino acid for protein synthesis; it is found in nature. There are two types of amino acids—L-glutamine and D-glutamine—that the body uses for different purposes, one of which is as a protein building block. Several meals and supplements made by chemical means include L-glutamine. There are supplements that call it glutamine, and there are supplements that call it L-glutamine.
Glutamine demand is lower than expected across all regions compared to pre-pandemic levels, which is a result of the unprecedented and overwhelming global COVID-19 pandemic. The glutamine (GLN) market is expected to grow and demand to revert to pre-pandemic levels once the pandemic ends, which is why the CAGR is going up. The market's big dogs had manufacturing and supply chain problems, so they couldn't meet consumer demand. The export-import ban led to a decrease in manufacturing, which in turn caused a glutamine (GLN) scarcity. Problems with logistics, raw material shortages, and a lack of available workers resulted from disrupted supply networks. Foods rich in glutamine, like beef, cattle, fowl, and dairy, had a decline in demand in 2020 due to a lack of supply. The demand for glutamine (GLN) and the expansion of the glutamine market were both impacted by these variables during the pandemic.
Glutamate demand is rising in the pharmaceutical industry due to trends in healthy eating and the rising prevalence of diseases like diabetes, cancer, Alzheimer's, and obesity. The pharmaceutical industry is booming, and medication research and development are gathering steam, as a result of the rising prevalence of numerous severe and potentially fatal diseases. Many medicinal products, including those for cancer, cystinuria, sickle cell anemia, anxiety, insomnia, AIDS, and gastrointestinal disorders such stomach ulcers, include glutamine. The need for glutamine in the pharmaceutical industry will be driven by its ever-growing list of uses.
Report Coverage
Global Glutamine (Gln) research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Glutamine (Gln) report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Glutamine (Gln) competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Glutamine (Gln) market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Glutamine (Gln) market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Glutamine (Gln) market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Ajinomoto (Japan), Kyowa Hakko Kirin (Japan), Daesang (South Korea), Meihua (China), Fufeng (China).
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Glutamine (Gln) market based on the below-mentioned segments:
Global Glutamine (Gln) Market, By Product Type
Pharmaceutical Grade
Nutraceutical Grade
Global Glutamine (Gln) Market, By End User
Nutraceutical Use
Pharmaceutical Use
Global Glutamine (Gln) market, Regional Analysis
The human body produces glutamine and other amino acids naturally. It is a crucial component of proteins and involved in many bodily functions. The correct functioning of muscles depends on glutamine, which is abundant in muscles. It helps with a lot of different biological functions, including the immune system and keeping the digestive tract healthy.
Additionally, the immune system cannot operate correctly without glutamine. It helps immune cells like macrophages and lymphocytes carry out their defense mechanisms by providing them with fuel. An important aspect of the immune defense system in humans is the gastrointestinal tract, which glutamine aids in preserving. And that's not all: glutamine aids in recuperation, wound healing, intestine health, and energy production. In addition, glutamine has many potential uses in the beauty and personal care industries.
The amino acid glutamine can be found in two distinct forms: L-glutamine and D-glutamine. The human body contains the D enantiomer of glutamine, which is called D-glutamine. It is involved in metabolic activities. It transports nitrogen across the body and provides energy to certain cells. However, L-glutamine calms intestinal tissues and increases immune cell activity, therefore reducing inflammation and infection in the gut. Additionally, it boosts immunity, helps with irritable bowel syndrome, and promotes digestive health.
Over the projected period, the global Glutamine (Gln) market is anticipated to maintain a consistent revenue CAGR, building on its robust performance in 2020. The existence of well-established enterprises worldwide, improvements in healthcare infrastructure, government programs aimed at raising public knowledge about the importance of health and wellness, and rising awareness about the need of maintaining immunological and gut health are all key drivers driving the market revenue growth.
Glutamine is a necessary amino acid for protein synthesis; it is found in nature. There are two types of amino acids—L-glutamine and D-glutamine—that the body uses for different purposes, one of which is as a protein building block. Several meals and supplements made by chemical means include L-glutamine. There are supplements that call it glutamine, and there are supplements that call it L-glutamine.
Glutamine demand is lower than expected across all regions compared to pre-pandemic levels, which is a result of the unprecedented and overwhelming global COVID-19 pandemic. The glutamine (GLN) market is expected to grow and demand to revert to pre-pandemic levels once the pandemic ends, which is why the CAGR is going up. The market's big dogs had manufacturing and supply chain problems, so they couldn't meet consumer demand. The export-import ban led to a decrease in manufacturing, which in turn caused a glutamine (GLN) scarcity. Problems with logistics, raw material shortages, and a lack of available workers resulted from disrupted supply networks. Foods rich in glutamine, like beef, cattle, fowl, and dairy, had a decline in demand in 2020 due to a lack of supply. The demand for glutamine (GLN) and the expansion of the glutamine market were both impacted by these variables during the pandemic.
Glutamate demand is rising in the pharmaceutical industry due to trends in healthy eating and the rising prevalence of diseases like diabetes, cancer, Alzheimer's, and obesity. The pharmaceutical industry is booming, and medication research and development are gathering steam, as a result of the rising prevalence of numerous severe and potentially fatal diseases. Many medicinal products, including those for cancer, cystinuria, sickle cell anemia, anxiety, insomnia, AIDS, and gastrointestinal disorders such stomach ulcers, include glutamine. The need for glutamine in the pharmaceutical industry will be driven by its ever-growing list of uses.
Report Coverage
Global Glutamine (Gln) research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Glutamine (Gln) report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Glutamine (Gln) competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Glutamine (Gln) market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Ajinomoto (Japan), Kyowa Hakko Kirin (Japan), Daesang (South Korea), Meihua (China), Fufeng (China). |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Glutamine (Gln) Market from 2021 to 2031.
- Market Forecast for Glutamine (Gln) Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Glutamine (Gln) competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Glutamine (Gln)
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Glutamine (Gln) market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Glutamine (Gln) market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Ajinomoto (Japan), Kyowa Hakko Kirin (Japan), Daesang (South Korea), Meihua (China), Fufeng (China).
Primary Target Market
- Market Players of Glutamine (Gln)
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Glutamine (Gln) market based on the below-mentioned segments:
Global Glutamine (Gln) Market, By Product Type
Pharmaceutical Grade
Nutraceutical Grade
Global Glutamine (Gln) Market, By End User
Nutraceutical Use
Pharmaceutical Use
Global Glutamine (Gln) market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive glutamine gln market market research and competitor analysis for your business to help you develop more profound insights into the glutamine gln market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the glutamine gln market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.